Patents
Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
10/2006
10/25/2006EP1187613B9 Amide substituted imidazoquinolines
10/25/2006CN1850828A Podophyllotoxin derivatives and their preparing method
10/25/2006CN1281607C Quaternary ammonium salt compound of piperazine with pain relieving effect
10/25/2006CN1281606C Nitrogen-containing heterocyclic compound
10/24/2006US7125995 Substituted amidoalkyl uracils and their use as inhibitors of the poly(adp-ribose) synthetase (PARS)
10/24/2006US7125878 For therapy and prophylaxis of cardiovascular diseases, diabetes, diabetes- associated disorders, inflammatory diseases, immunological disorders, dermatological disorders, oncological disorders and central nervous system disorders
10/24/2006CA2264598C 1,2,3,4-tetrahydro-benzofuro[3,2-c]pyridine derivatives
10/19/2006US20060235052 Disulfide, sulfide, sulfoxide, and sulfone derivatives of cyclic sugars and uses
10/19/2006US20060234327 Methods for identifying enzyme inhibitors and protein kinases
10/19/2006CA2603634A1 Novel isoindole derivatives, compositions containing same, preparation thereof and pharmaceutical uses thereof in particular as inhibitors of chaperone protein hsp90 activities
10/18/2006EP1711504A2 Derivatives of cephalosporin and clavulanic acid for detecting beta-lactamase in a sample
10/18/2006EP1711463A2 Amino-substituted tricyclic derivatives and methods of use
10/18/2006EP1392686B1 Bicyclic nitrogen-containing heterocyclic derivatives for use as antibacterials
10/18/2006CN1849323A Thienopyrroles as antiviral agents
10/18/2006CN1849322A Thienopyrazoles
10/18/2006CN1847247A 'One kettle process' of preparing cefozopran and its intermediate
10/17/2006US7122679 Multicyclic compounds and the use thereof
10/17/2006US7122572 For use in Hydrogen Bonding Liquid Chromatography, environmental remediation by removal of undesired ions or neutral molecules, removal of phosphate for kidney dialysis, drug delivery, separation
10/17/2006US7122540 2-Phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
10/12/2006WO2006108103A1 Purine and imidazopyridine derivatives for immunosuppression
10/12/2006US20060229303 antibiotics, fungicides, viricides; treating microbial infections; fused rings based on 1,4-benzoxazino(2,3,4-ij)quinolin-4-one for example
10/12/2006CA2604161A1 Purine and imidazopyridine derivatives for immunosuppression
10/11/2006EP1709957A2 Sustained-release analgesic compounds
10/11/2006EP1709052A1 Derivatives of 1,4-diazabicyclo 3.2.1octanecarboxamide, preparation method thereof and use of same in therapeutics
10/11/2006EP1709051A1 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
10/11/2006CN1279041C Diazabicyclo alkane derivatives with NK1 antagonistic activity
10/10/2006US7119204 phenanthroline compounds that exhibit electroluminescence, photoluminescence and/or photosensitivity, used in electrical apparatus such as organic light emitting diodes
10/10/2006US7119196 Anxiolytic agents with reduced sedative and ataxic effects
10/10/2006US7119087 4-(oxazolopyridin-2-yl)-1,4-diazabicyclo-[3.2.2]nonane derivatives, preparation and therapeutic use thereof
10/10/2006US7118811 Materials for light emitting devices consisting of novel compounds and light emitting devices using the same
10/10/2006CA2225366C Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them
10/10/2006CA2150804C Antiallergic triazolo(pyrrolo, thieno or furano)azepine derivatives
10/05/2006US20060223832 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
10/04/2006EP1707566A1 Deazapurines and uses thereof
10/04/2006EP1706403A2 Imidazo[4,5-c]pyridine compounds and methods of antiviral treatment
10/04/2006EP1474471B8 Process for preparing a synergistic stabilizer mixture
09/2006
09/28/2006WO2006100520A1 2,3-substituted fused pyrimidin-4(3h)-ones as vr1 antagonists
09/28/2006WO2006100038A1 Triazolopyrimidine derivatives useful as fungicides
09/28/2006WO2006100037A1 Triazolopyrimidine derivatives useful as microbiocides
09/28/2006US20060217538 for photoelectric conversion elements
09/28/2006US20060217411 2-Phenyl- pyrazoloquinolin-3-ones and pyrazolo(thio)chromen-3-ones, e.g., N-[4-(6-Fluoro-3-oxo-3,5-dihydropyrazolo[4,3-c]quinolin-2-yl)-phenyl]-2-methyl-butyramide; used to treat rheumatoid arthritis, multiple sclerosis, diabetes, asthma, transplantation, systemic lupus erythematosis and psoriasis
09/28/2006US20060217384 e.g. 1-((3-Phenyl-1,2,4-triazolo(3,4-a)phthalazines-6-yl)carbonyl)piperidine; high affinity to the benzodiazepine site of GABAA receptors; central nervous system (CNS) diseases such as depression, anxiety, and attention deficit disorder
09/28/2006US20060217361 Bicyclic 6-alkylidene-penems as beta-lactamase inhibitors
09/28/2006CA2602395A1 2,3-substituted fused pyrimidin-4(3h)-ones as vr1 antagonists
09/27/2006CN1839138A Substituted furochromene compounds of antiinflammatory action
09/26/2006US7112582 penicillins and oxapenicillins with a fused bicyclic N-heteroarymethylene group; 6-[(5-benzyl-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl)methylene]-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid; antibiotic resistance is reduced when administered alone or with other B-lactam antibiotics
09/21/2006US20060211758 M3 muscarinic acetylcholine receptor antagonists
09/21/2006US20060211704 2,4-Disubstituted thiazolyl derivatives
09/21/2006US20060209587 High density memory device
09/20/2006EP1702921A1 Beta-lactamase-resistant cephalosporin ester compounds and salts of thereof
09/20/2006EP1701962A2 Rifamycin analogs and uses thereof
09/20/2006CN1275970C Novel carbapenem derivatives
09/19/2006US7109213 Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them
09/19/2006US7109193 Tricyclic diazepines tocolytic oxytocin receptor antagonists
09/19/2006US7109192 dipeptidylpeptidase-IV inhibitors; treatment of diabetes and obesity
09/14/2006US20060205763 For therapy and prophylaxis of cardiovascular diseases, diabetes, diabetes- associated disorders, inflammatory diseases, immunological disorders, dermatological disorders, oncological disorders and central nervous system disorders
09/14/2006US20060205762 For therapy and prophylaxis of cardiovascular diseases, diabetes, diabetes- associated disorders, inflammatory diseases, immunological disorders, dermatological disorders, oncological disorders and central nervous system disorders
09/14/2006US20060205750 Cardiovascular disorders; central nervous system disorders; metabolic diseases; therapy for eating disorders; trans-2-(2-fluorophenyl)-8-[3'-oxospiro[cyclohexane-1,1'(3'H)-isobenzofuran]-4-yl]purine
09/13/2006EP1701347A2 Optical information-recording Medium, novel oxonol compound and method of recording information
09/13/2006EP1699797A1 Pyrrolotriazine compounds as kinase inhibitors
09/13/2006EP1483257B1 Quinazoline compounds useful in therapy
09/13/2006CN1833470A Compound, charge transporting material and organic electroluminescent element
09/13/2006CN1274675C Novel cyclobutene diketone compound and its producing process, and pharmaceutical composition containing the same compound
09/12/2006US7105550 2,4-disubstituted thiazolyl derivatives
09/12/2006US7105526 Benzimidazole derivatives
09/12/2006CA2180730C Substituted 3-arylidene-7-azaoxindole compounds and process for their preparation
09/07/2006US20060199823 Corticotropin releasing factor (CRF); affective disorders, anxiety disorders, stress-related disorders, eating disorders and substance abuse; eg 5-(1-Ethyl-propyl)-2-(2-methoxy-4-trifluoromethoxy-phenyl)-3,7-dimethyl-5H-pyrrolo[2,3-b]pyrazine
09/06/2006EP1698375A1 Azetidine ring compounds and drugs comprising the same
09/06/2006EP1697382A2 Rifamycin analogs and uses thereof
09/06/2006EP1696930A1 Tricyclic 1-((3-indol-3-yl)carbonyl)piperazine derivatives as cannabinoid cb1 receptor agonists
09/06/2006EP1562935B1 Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors
09/06/2006CN1273469C Tricyclic diazepines as tocolytic oxytocin receptor antagonists
09/05/2006USRE39267 Thienopyrimidine-based inhibitors of the SRC family
09/05/2006US7102016 Preparation of 2,2′-di(3,4-ethylenedioxythiophene)s
09/05/2006US7101891 Compounds and pharmaceutical compositions for inhibiting MRP1
09/05/2006US7101890 Benzazepine derivatives, drugs containing these and use of the same for producing drugs
08/2006
08/31/2006WO2006090272A1 Isoquinoline [1,8]naphthyridin-2-ones and related compounds for treatment of schizophrenia
08/31/2006WO2006090261A1 Bicyclic heteroaromatic derivatives useful as anticancer agents
08/31/2006US20060194871 Heterocyclic mchr1 antagoists
08/31/2006CA2598956A1 Bicyclic heteroaromatic derivatives useful as anticancer agents
08/30/2006EP1695977A2 Spiro [isobenzofuran-1,4'piperidin]-3-ones and 3H-spiroisobenzofuran-1, 4'-piperidines
08/30/2006EP1695960A1 Near-infrared fluorescent contrast medium
08/30/2006EP1694330A2 Vinorelbine derivatives
08/30/2006CN1826346A N-sulfonylheterocyclopyrrolylalkylamine compounds as 5-hydroxytryptamine-6 ligands
08/30/2006CN1826340A Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phoshorylase
08/30/2006CN1826333A Diamine derivatives
08/29/2006US7098242 administering a compound of dihydroartemisinin dimerized with 1, 2 or 1, 3 or 1, 4 glycol under acidic conditions; antiprotzoal agents, anti-tumor agents
08/29/2006US7098219 Inhibitors of cellular efflux pumps of microbes
08/29/2006US7098207 Imidazotriazinones and the use thereof
08/29/2006CA2268195C Azaheterocyclylmethyl derivatives of 2,3,8,9-tetrahydro-7h-1,4-dioxino[2,3-e]indol-8-one
08/24/2006WO2006088028A1 Method for producing 2-azaindolizine, method for producing 2-azaindolizine metal complex, and 2-azaindolizine metal complex
08/24/2006US20060189807 Process for the manufacture of intermediates in camptothecin production
08/24/2006US20060189615 2-Phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
08/24/2006US20060189604 Gramnegative and Grampositive bacterial infections; substituted Piperidine derivatives specially optionally substituted pyrido [3,2, -b][1,4] thiazin-yl; 6-({(3R,4S)-3-Fluoro-1-[(R)-2-hydroxy-2-(2-methoxy-quinolin-8-yl)-ethyl]-piperidin-4-ylamino }-methyl)-4H-pyrido[3,2-b][1,4]thiazin-3-one; nontoxic
08/24/2006US20060189601 Antibacterial agents
08/24/2006DE102005007223A1 Kontrastmittel für die Kernspintomographie unter Nutzung des Overhauser-Effekts Contrast agents for magnetic resonance imaging using the Overhauser effect
08/23/2006EP1539133B1 Aminocyclohexene quinolines and their azaisosteric analogues with antibacterial activity
08/23/2006EP1368358B1 Isoxazoline derivatives as anti-depressants
08/23/2006CN1823074A Process for synthesizing beta-lactamase inhibitor intermediates
08/23/2006CN1823069A Process for synthesizing beta-lactamase inhibitor intermediates
1 ... 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 ... 111